Skip to Content

Join the 'Betaseron' group to help and get support from people like you.

Betaseron News

Treating Early Symptoms of MS May Extend Time to Diagnosis

Posted 11 Aug 2016 by Drugs.com

THURSDAY, Aug. 11, 2016 – Starting multiple sclerosis (MS) treatment when the first signs of the disabling disease appear may delay the period before the condition is definitively diagnosed or a relapse occurs, new long-term research indicates. Researchers found that people who received early treatment for symptoms consistent with the onset of MS were one-third less likely to eventually be diagnosed with MS than participants whose treatment was delayed. Those symptoms include numbness, or vision or balance problems. Patients in the early treatment group also experienced a 19 percent lower annual relapse rate, the study found. "The surprise is that after 11 years, we were still able to detect a difference favoring early treatment, although the delay in starting treatment in the delayed treatment group was only 1.5 years on average," said study author Dr. Ludwig Kappos. He's a professor ... Read more

Related support groups: Multiple Sclerosis, Chronic Spasticity, Betaseron, Spasticity, Upper Limb Spasticity, Spinal Spasticity, Lower Limb Spasticity

FDA Approves Betaconnect Electronic Autoinjector for the Treatment of Relapsing-Remitting Multiple Sclerosis

Posted 28 Sep 2015 by Drugs.com

WHIPPANY, N.J., Sept. 25, 2015 /PRNewswire/ – Bayer HealthCare announced today that the U.S. Food and Drug Administration (FDA) approved Betaconnect, the first and only electronic autoinjector in the treatment of relapsing-remitting multiple sclerosis (RRMS). Betaconnect will be available exclusively to Betaseron (interferon beta-1b) patients beginning in early 2016. Betaseron is a prescription medicine used to reduce the number of relapses in people with relapsing forms of multiple sclerosis. This includes people who have had their first symptoms of multiple sclerosis and have an MRI consistent with multiple sclerosis. Betaseron will not cure MS but may decrease the number of flare-ups of the disease. After completing the preparation of Betaseron, patients may administer Betaseron by using the Betaconnect, which should only be used with the syringes provided in the Betaseron ... Read more

Related support groups: Multiple Sclerosis, Betaseron, Interferon Beta-1B

Neurology Group Lists Procedures That May Be Unneeded

Posted 8 Mar 2013 by Drugs.com

FRIDAY, March 8 – Five tests, procedures and treatments that neurologists and their patients should question are outlined in a list released by the American Academy of Neurology (AAN) as part of the Choosing Wisely campaign. "With one in six people affected by a brain disease, such as headache, multiple sclerosis and stroke, our goal is to have patients discuss our Choosing Wisely recommendations regarding medical procedures, therapies, and tests with their neurologists," AAN president Dr. Bruce Sigsbee said in an academy news release. The American Board of Internal Medicine Foundation-led Choosing Wisely campaign involves about 35 medical specialty groups and is intended to encourage patients and doctors to discuss appropriate care while avoiding unnecessary tests and treatments. The AAN is one of 17 medical societies that recently released advice lists. Here are the AAN's five ... Read more

Related support groups: Suboxone, Headache, Oxycodone, Hydrocodone, Methadone, OxyContin, Migraine, Vicodin, Norco, Fentanyl, Morphine, Codeine, Lortab, Opana, Subutex, Multiple Sclerosis, Dilaudid, Ischemic Stroke, Opana ER, Roxicodone

Drug Widely Used to Treat MS May Not Slow Progression

Posted 17 Jul 2012 by Drugs.com

TUESDAY, July 17 – Interferon beta, a widely used treatment for multiple sclerosis, does not stave off the time to disability, new research finds. However, prior studies have found that interferon beta does reduce MS flare ups, so patients should continue taking it, researchers said. The new study is published in the July 18 issue of the Journal of the American Medical Association. In multiple sclerosis, the body's immune system attacks myelin, or the substance that insulates nerve fibers of the central nervous system. The damage disrupts nerve signals traveling to and from the brain, which can lead to numbness, movement difficulties, blurred vision, fatigue and eventually, problems with thinking and memory. About 85 percent of those with multiple sclerosis start with a relapsing-remitting course, in which attacks are followed by partial or total recovery, according to the National ... Read more

Related support groups: Multiple Sclerosis, Avonex, Rebif, Betaseron, Interferon Beta-1A, Extavia, Interferon Beta-1B, Avonex Prefilled Syringe

FDA Medwatch Alert: Betaseron (interferon beta-1b)

Posted 22 Apr 2005 by Drugs.com

Berlex, Inc. reminded healthcare professionals of the prescribing information for Betaseron (interferon beta-1b) as it pertains to hepatic toxicity. Betaseron is approved for the treatment of relapsing forms of multiple sclerosis to reduce the frequency of clinical exacerbations. There have been reports during post-marketing safety surveillance of serious hepatic injury including autoimmune hepatitis and severe liver damage leading to hepatic failure and transplant. Liver function testing is recommended at regular intervals (one, three, and six months) following introduction to Betaseron therapy, and then periodically thereafter in the absence of clinical symptoms. [April 15, 2005 - Letter - Berlex][October 2003 - Label - Berlex] Read more

Related support groups: Betaseron

Ask a Question

Further Information

Related Condition Support Groups

Multiple Sclerosis, Colorectal Cancer, Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Betaseron Patient Information at Drugs.com